Medicine & Life Sciences
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
11%
Acute Myeloid Leukemia
5%
Antibodies
3%
Apoptosis
3%
B-Lymphocytes
4%
Cell Cycle
4%
Chemokines
11%
Chromosomes
4%
Clustered Regularly Interspaced Short Palindromic Repeats
6%
Cytokines
7%
Disease Progression
9%
Flow Cytometry
4%
Growth
5%
Hematologic Neoplasms
65%
Immune Evasion
81%
Immunoassay
5%
In Vitro Techniques
2%
Injections
3%
interferon gamma receptor
8%
Interferon-gamma
5%
Interleukin-1 Receptor-Associated Kinases
100%
Leukemia
43%
Lymphoma
34%
Methylation
5%
Molecular Biology
4%
mouse IFNG protein
8%
Myeloid-Derived Suppressor Cells
86%
Neoplasms
5%
Null Lymphocytes
7%
Receptor, Fibroblast Growth Factor, Type 1
95%
Signal Transduction
4%
Stem Cells
30%
T-Cell Leukemia
8%
T-Cell Lymphoma
6%
T-Lymphocytes
18%
Tail
5%
Veins
4%